Variations in Ultrasound Reporting on Patients Referred for Investigation of Ovarian Masses

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 10, 2008, Pages 902-906

  Le, Tien ^a   Fayadh, Ridhab Al ^a   Menard, Chantal ^a   Hicks Boucher, Wendy ^a   Faught, Wylam ^a   Hopkins, Laura ^a   Fung Kee Fung, Michael ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Ovarian mass; Standardization; Ultrasound examinations

Indexed keywords

CA 125 ANTIGEN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COLOR DOPPLER FLOWMETRY; COMMUNITY HOSPITAL; ECHOGRAPHY; FEMALE; GYNECOLOGY; HUMAN; MEDICAL RECORD; ONCOLOGY; OVARIAN MASS; OVARY DISEASE; PELVIC PAIN; PRIVATE HOSPITAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REPEAT PROCEDURE; TEACHING HOSPITAL; TERTIARY CARE CENTER; VERY ELDERLY; MEDICAL AUDIT; MIDDLE AGED; OVARY; PATIENT REFERRAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MEDICAL AUDIT; MIDDLE AGED; OVARY; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; YOUNG ADULT;

EID: 59649106142     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32970-X     Document Type: Article

References (37)

1. Borgfeldt C., Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol 1999, 13(5):345-350.
2. Schulman H., Conway C., Zalud I., Farmakides G., Haley J., Cassata M. Prevalence in a volunteer population of pelvic cancer detected with transvaginal ultrasound and color flow Doppler. Ultrasound Obstet Gynecol 1994, 4(5):414-420.
3. Conway C., Zalud I., Dilena M., Maulik D., Schulman H., Haley J., et al. Simple cyst in the postmenopausal patient: detection and management. J Ultrasound Med 1998, 17(6):369-372.
4. Sassone A.M., Timor-Tritsch I.E., Artner A., Westhoff C., Warren W.B. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991, 78(1):70-76.
5. Lerner J.P., Timor-Tritsch I.E., Federman A., Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol 1994, 170(1 Pt 1):81-85.
6. Asif N., Sattar A., Dawood M.M., Rafi T., Aamir M., Anwar M. Pre-operative evaluation of ovarian mass: risk of malignancy index. J Coll Physicians Surg Pak 2004, 14(3):128-131.
7. Tingulstad S., Hagen B., Skjeldestad F.E., Onsrud M., Kiserud T., Halvorsen T., et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996, 103(8):826-831.
8. Timmerman D, Van Calster B, Jurkovic D, Valentin L, Testa AC, Bernard JP, et al. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors. J Clin Oncol 4194-200. Epub 2007 Aug 13.
9. Bast R.C. How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above. J Clin Oncol 2007, 25(27):4159-4161. Epub 2007 Aug 13.
10. Timmerman D., Valentin L., Bourne T.H., Collins W.P., Verrelst H., Vergote I., International Ovarian Tumor Analysis (IOTA) Group Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000, 16(5):500-505.
11. Tailor A., Jurkovic D., Bourne T.H., Collins W.P., Campbell S. Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. Ultrasound Obstet Gynecol 1997, 10(1):41-47.
12. Tailor A., Jurkovic D., Bourne T.H., Natucci M., Collins W.P., Campbell S. A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer. Ultrasound Med Biol 1996, 22(7):837-843.
13. Sawicki W., Spiewankiewicz B., Cendrowski K., Stelmachów J. Preoperative discrimination between malignant and benign adnexal masses with transvaginal ultrasonography and colour blood flow imaging. Eur J Gynaecol Oncol 2001, 22(2):137-142.
14. Timmerman D., Testa A.C., Bourne T., Ferrazzi E., Ameye L., Konstantinovic M.L., et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005, 23(34):8794-8801.
15. Olson S.H., Mignone L., Nakraseive C., Caputo T.A., Barakat R.R., Harlap S. Symptoms of ovarian cancer. Obstet Gynecol 2001, 98(2):212-217.
16. Vine M.F., Calingaert B., Berchuck A., Schildkraut J.M. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol 2003, 90(1):75-82.
17. Goff B.A., Mandel L.S., Melancon C.H., Muntz H.G. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004, 291(22):2705-2712.
18. Goff B.A., Mandel L.S., Drescher C.W., Urban N., Gough S., Schurman K.M., et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007, 15(109(2)):221-227.
19. Tropé C., Kaern J. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Clin Oncol 2007, 25(20):2909-2920.
20. Trimbos J.B., Vergote I., Bolis G., Vermorken J.B., Mangioni C., Madronal C., et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003, 15(95(2)):113-125.
21. Jacobs I.J., Skates S.J., MacDonald N., Menon U., Rosenthal A.N., Davies A.P., et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 1999, 353(9160):1207-1210.
22. Menon U., Talaat A., Rosenthal A.N., Macdonald N.D., Jeyerajah A.R., Skates S.J., et al. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG 2000, 107(2):165-169.
23. van Nagell J.R., DePriest P.D., Ueland F.R., DeSimone C.P., Cooper A.L., McDonald J.M., et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer 2007, 109(9):1887-1896.
24. Jain K.A. Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings. Radiology 1994, 191(1):63-67.
25. Stein S.M., Laifer-Narin S., Johnson M.B., Roman L.D., Muderspach L.I., Tyszka J.M., et al. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. Am J Roentgenol 1995, 164(2):381-386.
26. Timmerman D., Schwärzler P., Collins W.P., Claerhout F., Coenen M., Amant F., et al. Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience. Ultrasound Obstet Gynecol 1999, 13(1):11-16.
27. Buy J.N., Ghossain M.A., Sciot C., Bazot M., Guinet C., Prévot S., et al. Epithelial tumors of the ovary: CT findings and correlation with US. Radiology 1991, 178(3):811-818.
28. Jain K.A., Friedman D.L., Pettinger T.W., Alagappan R., Jeffrey R.B., Sommer F.G. Adnexal masses: comparison of specificity of endovaginal US and pelvic MR imaging. Radiology 1993, 186(3):697-704.
29. Kinkel K., Hricak H., Lu Y., Tsuda K., Filly R.A. US characterization of ovarian masses: a meta-analysis. Radiology 2000, 217(3):803-811.
30. Jacobs I., Oram D., Fairbanks J., Turner J., Frost C., Grudzinskas J.G. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990, 97(10):922-929.
31. Andersen E.S., Knudsen A., Rix P., Johansen B. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol 2003, 90(1):109-112.
32. Manjunath A.P., Pratapkumar, Sujatha K., Vani R. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol 2001, 81(2):225-229.
33. Brown D.L., Doubilet P.M., Miller F.H., Frates M.C., Laing F.C., DiSalvo D.N., et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 1998, 208(1):103-110.
34. Buy J.N., Ghossain M.A., Hugol D., Hassen K., Sciot C., Truc J.B., et al. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. Am J Roentgenol 1996, 166(2):385-393.
35. Ferrazzi E., Zanetta G., Dordoni D., Berlanda N., Mezzopane R., Lissoni A.A. Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study. Ultrasound Obstet Gynecol 1997, 10(3):192-197.
36. Edhemovic I., Temple W.J., de Gara C.J., Stuart G.C. The computer synoptic operative report-a leap forward in the science of surgery. Ann Surg Oncol 2004, 11(10):941-947.
37. Hemmings C., Jeffery M., Frizelle F. Changes in the pathology reporting of rectal cancer: is it time to adopt synoptic reporting?. N Z Med J 2003, 116(1178):U513.